Low phospholipid arachidonic acid values in diabetic platelets.
- 15 January 1983
- Vol. 286 (6360), 173-175
- https://doi.org/10.1136/bmj.286.6360.173
Abstract
Platelet aggregation is enhanced in diabetes mellitus, and platelets may be implicated in the pathogenesis of diabetic angiopathy. Increased platelet aggregation is probably mediated by the production of the proaggregatory prostaglandin thromboxane, which is synthesised from arachidonic acid (C20:4) by the action of the platelet enzymes cyclo-oxygenase and thromboxane synthetase. The fatty acid composition of platelet phospholipid was measured in 20 normal controls, 10 insulin-treated diabetics with no or minimal retinopathy, and 10 insulin-treated diabetics with proliferative retinopathy. The percentage of arachidonic acid was significantly higher in controls (mean 22.6%) than in the diabetics with no or minimal retinopathy (mean 18.5%; p less than 0.025) and the diabetics with proliferative retinopathy (mean 14.6%; p less than 0.001). The percentage of linoleic acid was lower in controls (mean 8.9%) than in the diabetics with no or minimal retinopathy (mean 12.6%; p less than 0.01) and diabetics with proliferative retinopathy (mean 13.1%; p less than 0.001). The mean percentage of linolenic acid was significantly lower in the diabetics with proliferative retinopathy (2.7%) than in the normal control group (4.4%; p less than 0.01). A significant negative correlation was found between the percentages of arachidonic acid and glycosylated haemoglobin (Rs = -0.58; p less than 0.001). A significant positive correlation was found between linoleic acid and the percentage of glycosylated haemoglobin (Rs = 0.51; p less than 0.01). The reciprocal correlation between percentages of arachidonic acid and glycosylated haemoglobin suggests that diabetic control may influence thromboxane release and platelet activity directly and that low percentages of arachidonic acid reflect the increased degree of in-vivo activation.This publication has 20 references indexed in Scilit:
- Factors protective against retinopathy in insulin-dependent diabetics free of retinopathy for 30 yearsBMJ, 1982
- ABNORMALITIES OF ERYTHROCYTE DEFORMABILITY AND PLATELET AGGREGATION IN INSULIN-DEPENDENT DIABETICS CORRECTED BY INSULIN IN VIVO AND IN VITROThe Lancet, 1982
- EFFECTS OF 11-WEEK INCREASE IN DIETARY EICOSAPENTAENOIC ACID ON BLEEDING TIME, LIPIDS, AND PLATELET AGGREGATIONThe Lancet, 1981
- Platelet functions in relation to diet and serum lipids in British farmers.Heart, 1981
- Prostacyclin and thromboxane in diabetes.BMJ, 1981
- PLATELET-MEMBRANE FATTY ACIDS, PLATELET AGGREGATION, AND THROMBOXANE FORMATION DURING A MACKEREL DIETThe Lancet, 1980
- HÆMOSTATIC FUNCTION AND PLATELET POLYUNSATURATED FATTY ACIDS IN ESKIMOSThe Lancet, 1979
- Decreased Vascular Prostacyclin in Juvenile-Onset DiabetesNew England Journal of Medicine, 1979
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- Lipoprotein fractionation by a precipitation method. a simple quantitative procedureClinica Chimica Acta; International Journal of Clinical Chemistry, 1976